Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Bolag Altan
Kyoichi Kaira
Akira Watanabe
Norio Kubo
Pinjie Bao
Gantumur Dolgormaa
Erkhem-Ochir Bilguun
Kenichiro Araki
Yoshikatsu Kanai
Takehiko Yokobori
Tetsunari Oyama
Masahiko Nishiyama
Hiroyuki Kuwano
Ken Shirabe
机构：
[1] Gunma University Graduate School of Medicine,Department of Oncology Clinical Development
[2] Gunma University Graduate School of Medicine,Department of Hepatobiliary and Pancreatic Surgery
[3] Gunma University Graduate School of Medicine,Department of General Surgical Science
[4] Gunma University Graduate School of Medicine,Department of Molecular Pharmacology and Oncology
[5] Osaka University,Department of Bio
[6] Gunma University Initiative for Advanced Research,system Pharmacology, Graduate School of Medicine
[7] Gunma University Graduate School of Medicine,Division of Integrated Oncology Research, Research Program for Omics
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
LAT1; Pancreatic cancer; Prognosis; Chemotherapy; Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 153
页数：12
相关论文
共 50 条
  • [21] Prognostic significance of LAT1 expression in pleural mesothelioma
    Taguchi, Ryo
    Kaira, Kyoichi
    Miura, Yu
    Umesaki, Tetsuya
    Mouri, Atsuto
    Imai, Hisao
    Kagamu, Hiroshi
    Yasuda, Masanori
    Kanai, Yoshikatsu
    Nitanda, Hiroyuki
    Ishida, Hironori
    Sakaguchi, Hirozo
    HELIYON, 2024, 10 (17)
  • [22] Evidence of LAT1 expression in canine caput epididymis
    Ogihara, Kikumi
    Onda, Ken
    Sato, Reiichiro
    Naya, Yuko
    Ochiai, Hideharu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2015, 77 (01): : 85 - 88
  • [23] Lumican Expression in Pancreatic Ductal Adenocarcinoma
    Yang, Zhao-Xu
    Lu, Cheng-Yi
    Yang, Yan-Ling
    Dou, Ke-Feng
    Tao, Kai-Shan
    HEPATO-GASTROENTEROLOGY, 2013, 60 (122) : 349 - 353
  • [24] Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma
    Kohi, Shiro
    Sato, Norihiro
    Cheng, Xiao-Bo
    Koga, Atsuhiro
    Hirata, Keiji
    PANCREAS, 2016, 45 (10) : 1467 - 1473
  • [25] Correlation Between the Acquisition of Resistance to Gemcitabine Therapy and the Expression of HuR in Pancreatic Ductal Adenocarcinoma: A Case Report
    Oba, Atsushi
    Ban, Daisuke
    Kudo, Atsushi
    Kirimura, Susumu
    Ito, Hiromitsu
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Aihara, Arihiro
    Ochiai, Takanori
    Tanaka, Shinji
    Tanabe, Minoru
    INTERNATIONAL SURGERY, 2018, 103 (1-2) : 116 - 120
  • [26] AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
    Sapio, Luigi
    Ragone, Angela
    Spina, Annamaria
    Salzillo, Alessia
    Naviglio, Silvio
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 625 - 636
  • [27] Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma
    Shah, Ashu
    Ganguly, Koelina
    Rauth, Sanchita
    Sheree, Shamema S.
    Khan, Imran
    Ganti, Apar K.
    Ponnusamy, Moorthy P.
    Kumar, Sushil
    Jain, Maneesh
    Batra, Surinder K.
    DRUG RESISTANCE UPDATES, 2024, 77
  • [28] Pancreatic ductal adenocarcinoma: Role of chemotherapy & future perspectives
    Tiwari, Akash
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (03) : 254 - 257
  • [29] RELATIONSHIP ANALYSIS BETWEEN HUMAN ABO BLOOD GROUP AND PANCREATIC DUCTAL ADENOCARCINOMA
    Wang Lianmin
    Shi Yanmei
    Tang Zhiyi
    Liu Yaqiong
    He Haiyu
    Wang Tao
    Su Kun
    Wang Kun
    Chang Jiang
    Wu Tao
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 377 - 381
  • [30] Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
    Bian, Yun
    Guo, Shiwei
    Jiang, Hui
    Gao, Suizhi
    Shao, Chenwei
    Cao, Kai
    Fang, Xu
    Li, Jing
    Wang, Li
    Hua, Wenda
    Zheng, Jianming
    Jin, Gang
    Lu, Jianping
    PANCREAS, 2019, 48 (09) : 1195 - 1203
12345